Literature DB >> 22315500

Hemoglobin sickle cell disease complications: a clinical study of 179 cases.

François Lionnet1, Nadjib Hammoudi, Katia Stankovic Stojanovic, Virginie Avellino, Gilles Grateau, Robert Girot, Jean-Philippe Haymann.   

Abstract

BACKGROUND: Hemoglobin sickle cell disease is one of the most frequent hemoglobinopathies. Surprisingly, few studies have been dedicated to this disease, currently considered to be a mild variant of homozygous sickle cell disease. The aim of this study was to update our knowledge about hemoglobin sickle cell disease. DESIGN AND METHODS: The study involved a single center series of 179 patients. Clinical and biological data were collected with special attention to the assessment of pulmonary arterial hypertension and nephropathy.
RESULTS: Hemoglobin sickle cell diagnosis was delayed and performed in adulthood in 29% of cases. Prevalence of hospitalized painful vasoocclusive crisis, acute chest syndrome and priapism was 36%, 20% and 20%, respectively. The most common chronic organ complications were retinopathy and sensorineural otological disorders in 70% and 29% of cases. Indeed, prevalence of complications reported in homozygous sickle cell disease, such as nephropathy, suspicion of pulmonary hypertension, strokes and leg ulcers was rather low (13%, 4% and 1%, respectively). Phlebotomy performed in 36% of this population (baseline hemoglobin 11.5 g/dL) prevented recurrence of acute events in 71% of cases.
CONCLUSIONS: Our data suggest that hemoglobin sickle cell disease should not be considered as a mild form of sickle cell anemia but as a separate disease with a special emphasis on viscosity-associated otological and ophthalmological disorders, and with a low prevalence of vasculopathy (strokes, pulmonary hypertension, ulcers and nephropathy). Phlebotomy was useful in reducing acute events and a wider use of this procedure should be further investigated.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22315500      PMCID: PMC3409809          DOI: 10.3324/haematol.2011.055202

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  41 in total

1.  S-C hemoglobin: a clinical study.

Authors:  G L RIVER; A B ROBBINS; S O SCHWARTZ
Journal:  Blood       Date:  1961-10       Impact factor: 22.113

2.  Hearing disorders in sickle cell disease: cochlear and retrocochlear findings.

Authors:  H J Gould; M R Crawford; W R Smith; N Beckford; W R Gibson; L Pettit; L Bobo
Journal:  Ear Hear       Date:  1991-10       Impact factor: 3.570

3.  Prevalence of hearing loss in adults with sickle cell disease.

Authors:  M R Crawford; H J Gould; W R Smith; N Beckford; W R Gibson; L Bobo
Journal:  Ear Hear       Date:  1991-10       Impact factor: 3.570

4.  Early glomerular dysfunction in patients with sickle cell anemia.

Authors:  F Schmitt; F Martinez; G Brillet; I Giatras; G Choukroun; R Girot; D Bachir; F Galacteros; B Lacour; J P Grünfeld
Journal:  Am J Kidney Dis       Date:  1998-08       Impact factor: 8.860

5.  Leg ulcers in patients with sickle cell disease.

Authors:  M Koshy; R Entsuah; A Koranda; A P Kraus; R Johnson; R Bellvue; Z Flournoy-Gill; P Levy
Journal:  Blood       Date:  1989-09       Impact factor: 22.113

6.  Acute multiorgan failure syndrome: a potentially catastrophic complication of severe sickle cell pain episodes.

Authors:  K L Hassell; J R Eckman; P A Lane
Journal:  Am J Med       Date:  1994-02       Impact factor: 4.965

7.  Mortality in sickle cell disease. Life expectancy and risk factors for early death.

Authors:  O S Platt; D J Brambilla; W F Rosse; P F Milner; O Castro; M H Steinberg; P P Klug
Journal:  N Engl J Med       Date:  1994-06-09       Impact factor: 91.245

8.  Molecular and cellular pathogenesis of hemoglobin SC disease.

Authors:  H F Bunn; C T Noguchi; J Hofrichter; G P Schechter; A N Schechter; W A Eaton
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

9.  Protein and energy metabolism in prepubertal children with sickle cell anemia.

Authors:  E K Salman; M W Haymond; E Bayne; B K Sager; A Wiisanen; P Pitel; D Darmaun
Journal:  Pediatr Res       Date:  1996-07       Impact factor: 3.756

10.  Improvement of sickle cell anemia by iron-limited erythropoiesis.

Authors:  O Castro; W N Poillon; H Finke; E Massac
Journal:  Am J Hematol       Date:  1994-10       Impact factor: 10.047

View more
  37 in total

1.  Subclinical left ventricular systolic impairment in steady state young adult patients with sickle-cell anemia.

Authors:  Nadjib Hammoudi; Dimitri Arangalage; Morad Djebbar; Katia Stankovic Stojanovic; Magali Charbonnier; Richard Isnard; Robert Girot; Pierre-Louis Michel; François Lionnet
Journal:  Int J Cardiovasc Imaging       Date:  2014-06-22       Impact factor: 2.357

2.  Human bulbar conjunctival hemodynamics in hemoglobin SS and SC disease.

Authors:  Justin Wanek; Bruce Gaynes; Jennifer I Lim; Robert Molokie; Mahnaz Shahidi
Journal:  Am J Hematol       Date:  2013-06-12       Impact factor: 10.047

3.  [Hemoglobin disorders].

Authors:  R Dickerhoff
Journal:  Internist (Berl)       Date:  2015-09       Impact factor: 0.743

Review 4.  2015 Clinical trials update in sickle cell anemia.

Authors:  Natasha Archer; Frédéric Galacteros; Carlo Brugnara
Journal:  Am J Hematol       Date:  2015-10       Impact factor: 10.047

5.  Co-inheritance of a-thalassemia dramatically decreases the risk of acute splenic sequestration in a large cohort of newborns with hemoglobin SC.

Authors:  Paulo V Rezende; André R Belisário; Érica L Oliveira; Jéssica A Almeida; Larissa M M Oliveira; Maristela B S R Muniz; Marcos B Viana
Journal:  Haematologica       Date:  2019-01-10       Impact factor: 9.941

6.  Hemoglobin sickle cell disease in Brazil.

Authors:  Ana Carolina Cabañas-Pedro; Josefina A P Braga; Roberta F Camilo-Araújo; Ana I M Silva; Perla Vicari; Maria Figueiredo
Journal:  Haematologica       Date:  2013-01       Impact factor: 9.941

7.  Hematologic and hemorheological determinants of resting and exercise-induced hemoglobin oxygen desaturation in children with sickle cell disease.

Authors:  Xavier Waltz; Marc Romana; Marie-Laure Lalanne-Mistrih; Roberto F Machado; Yann Lamarre; Vanessa Tarer; Marie-Dominique Hardy-Dessources; Benoît Tressières; Lydia Divialle-Doumdo; Marie Petras; Frederic Maillard; Maryse Etienne-Julan; Philippe Connes
Journal:  Haematologica       Date:  2013-03-28       Impact factor: 9.941

8.  Impaired blood rheology plays a role in the chronic disorders associated with sickle cell-hemoglobin C disease.

Authors:  Nathalie Lemonne; Yann Lamarre; Marc Romana; Marie-Dominique Hardy-Dessources; François Lionnet; Xavier Waltz; Vanessa Tarer; Danielle Mougenel; Benot Tressières; Marie-Laure Lalanne-Mistrih; Maryse Etienne-Julan; Philippe Connes
Journal:  Haematologica       Date:  2014-03-14       Impact factor: 9.941

Review 9.  Knowledge insufficient: the management of haemoglobin SC disease.

Authors:  Lydia H Pecker; Beverly A Schaefer; Lori Luchtman-Jones
Journal:  Br J Haematol       Date:  2016-12-16       Impact factor: 6.998

10.  Original Research: Use of hydroxyurea and phlebotomy in pediatric patients with hemoglobin SC disease.

Authors:  Carly C Ginter Summarell; Vivien A Sheehan
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.